A phase II study of the efficacy and safety of sunitinib in treatment-naïve and pretreated Japanese patients (pts) with metastatic renal cell carcinoma (mRCC)
A phase II study of the efficacy and safety of sunitinib in treatment-naïve and pretreated Japanese patients (pts) with metastatic renal cell carcinoma (mRCC)
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started